Form 4: Caris Life Sciences President's Stock Tax Withholding

Caris Life Sciences President David Spetzler reported a disposition of 63,509 common shares at $29.75 for tax obligations under a pre-arranged plan.

Summary

• David Baxley Spetzler, President of Caris Life Sciences, Inc. (CAI), reported a disposition of 63,509 shares of common stock.
• The transaction is scheduled for August 11, 2025, at a price of $29.75 per share.
• This disposition was coded as 'F,' indicating shares are to be withheld to cover tax liabilities.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, signifying a pre-arranged, non-discretionary sale.
• Following this transaction, Spetzler will directly beneficially own 460,377 shares of common stock.

Sentiment

Score: 6

Explanation: The transaction is a routine tax-related disposition under a pre-arranged plan, which is neutral to slightly positive as it's not a discretionary sale. The future date reflects a scheduled vesting event.

Positives

• The transaction is executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled, non-discretionary event rather than a discretionary sale based on insider sentiment.
• The disposition is for tax withholding, which is a common and expected event when equity compensation vests.

Negatives

• A reduction in direct beneficial ownership by a key executive, even if for tax purposes, slightly decreases their direct equity stake in the company.

Future Outlook

NA

Industry Context

This type of insider transaction, specifically for tax withholding, is a routine event across industries when executives receive equity compensation that vests, requiring shares to be sold or withheld to cover tax obligations.

Comparison to Industry Standards

• The disposition of shares for tax withholding is a standard practice for equity compensation across publicly traded companies.
• It is not indicative of a specific company or industry performance issue but rather a common mechanism for managing tax liabilities on vested stock awards.
• Comparable events occur regularly at companies like Apple (AAPL), Microsoft (MSFT), or Google (GOOGL) when their executives' restricted stock units vest.

Related Party Transactions

• The disposition of shares by President David Baxley Spetzler to cover tax liabilities on equity compensation is a related party transaction, as it involves an executive and the company's securities.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the non-discretionary nature mitigates negative sentiment.
• Employees: No direct impact beyond the executive involved.

Key Dates

Recommendation

The filing details a routine, non-discretionary disposition of shares by an insider for tax withholding purposes under a Rule 10b5-1 plan. This type of transaction is common for executives receiving equity compensation and does not typically signal a change in company fundamentals or insider sentiment. Therefore, it provides no new information that would warrant a change in investment recommendation.

Keywords

Caris Life Sciences, CAI, SEC Form 4, Insider Trading, Stock Disposition, David Spetzler, Tax Withholding, 10b5-1 Plan, Equity Compensation